Inhibrx Biosciences, Inc. business relationships
Companies named in Inhibrx Biosciences, Inc.’s 10-K filed 2026-03-19, and public companies whose annual reports name Inhibrx Biosciences, Inc.. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.
- AEO visibility
- 4.9 / 10
- AI naming
- 23 / 100 Top 5% in its category
- Agent readiness
- 25 / 100
- AI adoption
- 0 / 100
Named in Inhibrx Biosciences, Inc.’s annual report 1
“...e revenue during the year ended December 31, 2024 was $0.2 million and consisted of revenue related to our license agreement with Regeneron Pharmaceuticals, Inc., which we recognized following the grant of two six-month extensions of the option term during the year, each for revenue of $0.1 million.” SEC filing
Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.